The RheumNow Week in Review – 6 January 2017-YouTube Save
Join The Discussion
In regards to the Finnish study on TNF inhibitor survival, I suspect the results would be even more in the USA as many"sero-negative" RA patients who are presumed to have RA or "inflammatory arthritis" (not to mention the ever-growing number of nr-axSpA patients) receive a trial of empiric therapy with biologic biologic agents that don't pan out. As the saying goes, "you see what you know" and there is a lot we still don't know about this group of" RA-look alikes".
If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.